Exactech Inc (EXAC)

25.40
NASDAQ : Health Care
Prev Close 26.35
Day Low/High 24.35 / 26.20
52 Wk Low/High 16.59 / 28.66
Avg Volume 31.00K
Exchange NASDAQ
Shares Outstanding 14.18M
Market Cap 373.77M
EPS 1.10
P/E Ratio 23.32
Div & Yield N.A. (N.A)

Latest News

Exactech Breaks Ground In Foot And Ankle Market With Successful First Surgery

Exactech Breaks Ground In Foot And Ankle Market With Successful First Surgery

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, hip, knee, and spine, announced today a successful first surgery using its new Vantage® Total Ankle...

New Studies Support Exactech's Knee, Shoulder And Computer-Assisted Surgery Technologies

New Studies Support Exactech's Knee, Shoulder And Computer-Assisted Surgery Technologies

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, today reported that studies involving its knee and shoulder joint replacement innovations and...

Exactech Expands Its Computer-Assisted Surgery System With Revision Total Knee Replacement Application

Exactech Expands Its Computer-Assisted Surgery System With Revision Total Knee Replacement Application

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, today announced today the successful first U.

Dr. Pierre-Henri Flurin, MD, A Shoulder Specialist At The Clinique Du Sport In Bordeaux-Mérignac, France, Performed Both An Anatomic And A Reverse Total Shoulder Replacement Using Exactech's Equinoxe® Shoulder System Implants And Instruments. (Photo: Business Wire)

Dr. Pierre-Henri Flurin, MD, A Shoulder Specialist At The Clinique Du Sport In Bordeaux-Mérignac, France, Performed Both An Anatomic And A Reverse Total Shoulder Replacement Using Exactech's Equinoxe® Shoulder System Implants And Instruments. (Photo: Business Wire)

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, today announced positive surgeon feedback on first surgeries performed with the...

Exactech Announces Investor Presentation At Baird Global Healthcare Conference

Exactech Announces Investor Presentation At Baird Global Healthcare Conference

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologics, will present to investors at the Baird 2016 Global Healthcare Conference...

This Little-Known Orthopedic-Device Stock Is Delivering Huge Returns

This Little-Known Orthopedic-Device Stock Is Delivering Huge Returns

Even though it has huge, better-known rivals, Exactech (EXAC) is the best-performing stock in the orthopedic products sector this year.

Exactech Q2 Revenue Up 8% To $66.1 Million; Net Income Up 20% To $4.4 Million; Diluted EPS $0.31 Vs. $0.26

Exactech Q2 Revenue Up 8% To $66.1 Million; Net Income Up 20% To $4.4 Million; Diluted EPS $0.31 Vs. $0.26

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, today announced revenue of $66.

Exactech Schedules Second Quarter 2016 Earnings Release And Conference Call

Exactech Schedules Second Quarter 2016 Earnings Release And Conference Call

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologics, will release its second quarter financial results after the market...

Exactech Announces Full Launch Of Acapella® One Cervical Spacer System

Exactech Announces Full Launch Of Acapella® One Cervical Spacer System

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, knee, hip and spine, announced today the full launch of the new Acapella® One...

Exactech Expands Competency In 3-D Printing With Purchase Of Arcam Q10plus Systems

Exactech Expands Competency In 3-D Printing With Purchase Of Arcam Q10plus Systems

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, knee, hip and spine, has confirmed the purchase of two Arcam Q10plus machines this...

A Drawing Depicts Plans To Recognize The Newly Named Exactech Arena At The Stephen C. O'Connell Center, A Sports And Entertainment Complex At The University Of Florida In Gainesville, Fl. The Remodeled Facility Is Scheduled To Re-open In December 2016. (Photo: Business Wire)

A Drawing Depicts Plans To Recognize The Newly Named Exactech Arena At The Stephen C. O'Connell Center, A Sports And Entertainment Complex At The University Of Florida In Gainesville, Fl. The Remodeled Facility Is Scheduled To Re-open In December 2016. (Photo: Business Wire)

Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, knee, hip and spine, announced today an expansion of its long-standing partnership with the...

Exactech Commemorates 20 Years On Nasdaq With A Proven Record Of Growth. Exactech Is A Developer And Producer Of Bone And Joint Restoration Products And Biologic Materials For Extremities, Knee, Hip And Spine. (Nasdaq: EXAC)(Graphic: Business Wire)

Exactech Commemorates 20 Years On Nasdaq With A Proven Record Of Growth. Exactech Is A Developer And Producer Of Bone And Joint Restoration Products And Biologic Materials For Extremities, Knee, Hip And Spine. (Nasdaq: EXAC)(Graphic: Business Wire)

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, knee, hip and spine, announced today that in honor of the company's 20th...

Exactech Q1 Revenue Up 6% To $65.3 Million

Exactech Q1 Revenue Up 6% To $65.3 Million

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, today announced revenue of $65.

Exactech Receives FDA 510(k) Clearance For Vantage™ Total Ankle

Exactech Receives FDA 510(k) Clearance For Vantage™ Total Ankle

Exactech Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologic materials, announced today it has received clearance from the U.

Exactech Schedules First Quarter 2016 Earnings Release And Conference Call

Exactech Schedules First Quarter 2016 Earnings Release And Conference Call

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologics, will release its first quarter financial results after the market closes...

Insider Trading Alert - AGNC, EXAC And TRC Traded By Insiders

Insider Trading Alert - AGNC, EXAC And TRC Traded By Insiders

Stocks with insider trader activity include AGNC, EXAC and TRC

Exactech Announces Completion Of Corporate Integrity Agreement Requirements

Exactech Announces Completion Of Corporate Integrity Agreement Requirements

Exactech Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologic materials, announced today that it has completed the requirements of its five-year...

Exactech Innovations Presented At 2016 Orthopaedic Research Society Annual Meeting

Exactech Innovations Presented At 2016 Orthopaedic Research Society Annual Meeting

Exactech Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologic materials, will present more than 25 scientific posters and presentations regarding...

Exactech Innovations Simplify The Complexity Of Revision Total Joint Replacement

Exactech Innovations Simplify The Complexity Of Revision Total Joint Replacement

Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologic solutions, announced today its lineup of products to be unveiled at the company's...

Exactech 2015 Revenue $241.8 Million, Net Income $14.8 Million, EPS $1.04

Exactech 2015 Revenue $241.8 Million, Net Income $14.8 Million, EPS $1.04

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologics, announced today that revenue for 2015 decreased 3% to $241.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BGG, DLB, EXAC, POPE, VTR, WERN Downgrades: ARKR, CAMT, CETX, CYH, ELNK, FET, NYRT, ULBI Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Exactech Schedules Fourth Quarter And Year End 2015 Earnings Release And Conference Call

Exactech Schedules Fourth Quarter And Year End 2015 Earnings Release And Conference Call

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologics, will release its fourth quarter and year end 2015 financial results...

Exactech Acquires Australian Distributor

Exactech Acquires Australian Distributor

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologics, announced today the acquisition of its independent distribution partner,...

Exactech Announces The Sale Of Its Dental Biologic Assets To Salvin Dental Specialties

Exactech Announces The Sale Of Its Dental Biologic Assets To Salvin Dental Specialties

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today the sale of substantially all of the assets of its dental biologics business...

Exactech Announces Renewal Of $150 Million Senior Secured Debt Credit Facility

Exactech Announces Renewal Of $150 Million Senior Secured Debt Credit Facility

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today the five year renewal and increase of its Senior Secured Revolving Credit...

Exactech Announces Stock Repurchase Authorization

Exactech Announces Stock Repurchase Authorization

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today that its board of directors has authorized the company to buy back up to 1.

Bearish Bets: Small-Cap Energy Names Like Range Resources Get Crushed

RRC, EXAC, ALXN, AMAG and DK were all recently downgraded by TheStreet’s Quant Ratings.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AOSL, BKU, CFNB, CSS, CUI, ESRT, GTY, REXR, RNET, TNAV Downgrades: ABC, ALLE, ALXN, CVI, EXAC, HT, JAH, MDP, MYE, OSK, ROG, UHT, WHF Initiations: None Read on to get TheStreet Quant Ratings' detailed report: